Home Search

influenza - search results

If you're not happy with the results, please do another search
vector-borne diseases, infectious diseases

How will a changing climate affect the future of vector borne diseases?

With a changing climate, animal, insect, and plant species will either adapt or die under new environmental and climate conditions - this brings new challenges in the study of vector-borne infectious diseases.
first malaria vaccine

Malaria deaths reduced by 70% with vaccine and drug combination

A combination of the world’s first malaria vaccine RTS,S/AS01E and antimalarial drugs reduce child hospitalisations and death by 70%.
vaccination logistics

COVID-19: Challenges of vaccination logistics

The challenges of vaccination logistics during the COVID-19 pandemic are charted in this updated view, written by Zisis Kozlakidis and John Litaker.
racial disparities in vaccination, vaccination uptake

US study says racial disparities in vaccination problematic for 10 years

Scientists, looking at the US population, reveal that racial disparities in vaccination have been an ongoing issue for the last ten years.
intranasal COVID vaccines, clinical trial

Immunologists push for more intranasal COVID vaccines

While intramuscular vaccines are the norm right now, immunologists propose that intranasal COVID vaccines would be great for booster shots.
Vaccines and viral threats

Tailoring the immune system to viral threats

How viral vaccines work and why they are effective in curbing human viral disease - Pamela J. Lein and colleagues discuss in detail.
flu jab

Flu jab will be freely available to more than 35 million people this winter

Health and Social Care Secretary Sajid Javid has announced that over 35 million people will have access to a free flu vaccine this winter.
vaccination campaigns

Supporting vaccination campaigns through high-quality cold storage solutions

Arthur Goudena, Marketing Manager of PHC Europe, explains how the company’s cold storage solutions are available to support COVID-19 vaccination campaigns across Europe.
break the glycocode, SIB swiss institute of bioinformatics

Bioinformatics focus: Can we break the glycocode?

Frederique Lisacek from SIB Swiss Institute of Bioinformatics, provides the computer-based tools for exploring ways of breaking the glycocode.
pig farming

SWINOSTICS: Field-diagnostics in pig farming

Here, R&D Director Alessandro Giusti details the work of the Horizon 2020 funded SWINOSTICS project to tackle viruses causing epidemics in pig farming.
vaccine rollout

Communication strategies are critical for vaccine rollout

Adam Enterkin, Global SVP Sales at BlackBerry, explores the critical role of secure crisis communications for the vaccine rollout and the value of a communication strategy to combat misinformation.
immunotherapeutics

Immune system research: Vaccines and immunotherapeutics

Dr Babita Agrawal, Professor at the University of Alberta, discusses both the vital present and future roles of vaccines and immunotherapeutics in combatting COVID-19.
hospitalised COVID patients, obesity COVID

Study finds 30.8% of hospitalised COVID patients are obese

An international study examined hospitalised COVID patients across 11 countries - finding that obese patients are 73% more likely to need invasive respiratory support.
addressing health inequality

A long-term collaborative approach to addressing health inequality

Christine Hancock, Founder and Director at C3 Collaborating for Health, discusses the ongoing issue of health inequality that COVID-19 has exposed, and how to ensure healthy lives for all.
obesity and COVID-19

What do we know about obesity and COVID-19?

Dr Deborah Lee, Dr Fox Online Pharmacy, highlights the possible reasons why being obese affects the risk of COVID-19 infection.
pandemic disease

Plague: The first pandemic disease

Ann G. Matthysse, Professor of Biology from The University of North Carolina at Chapel Hill, writes in detail about plague, the first pandemic disease including comment on bacteria.
biological air treatment, renewable

Sterilair PRO – Biological air treatment

Used in medical settings for over 20 years, Sterilair is now being used in a wide range of close-contact environments to maintain healthy air quality.
HERA incubator, manufacturing

Commission launches “HERA Incubator” project to fight COVID mutations

The European Commission today (17 February) launched the "HERA Incubator", as both a "blueprint" for long-term health emergencies and a way to stop COVID-19 mutations.
virus variants

UK Government and CureVac partnership to tackle COVID-19 virus variants

The UK Government and vaccine manufacturer CureVac have partnered to rapidly develop new vaccines in response to new COVID-19 virus variants.
get COVID-19 vaccine

Third of Americans say they are unlikely to get COVID-19 vaccine

A new study by the University of California, Davis has found that a third of Americans are either unlikely or hesitant to get a COVID-19 vaccine when it becomes available.

Follow Open Access Government